Cardiovascular benefits of lycopene

fantasy or reality?

Frank Thies, Lynsey Margaret Mills, Susan Moir, Lindsey F. Masson

Research output: Contribution to journalArticle

17 Citations (Scopus)
9 Downloads (Pure)

Abstract

Epidemiological evidence indicates that high consumption of tomatoes and tomato-based products reduces the risk of chronic diseases such as CVD and cancer. Such potential benefits are often ascribed to high concentrations of lycopene present in tomato products. Mainly from the results of in vitro studies, potential biological mechanisms by which carotenoids could protect against heart disease and cancer have been suggested. These include cholesterol reduction, inhibition of oxidation processes, modulation of inflammatory markers, enhanced intercellular communication, inhibition of tumourigenesis and induction of apoptosis, metabolism to retinoids and antiangiogenic effects. However, with regard to CVD, results from intervention studies gave mixed results. Over fifty human intervention trials with lycopene supplements or tomato-based products have been conducted to date, the majority being underpowered. Many showed some beneficial effects but mostly on non-established cardiovascular risk markers such as lipid peroxidation, DNA oxidative damage, platelet activation and inflammatory markers. Only a few studies showed improvement in lipid profiles, C reactive protein and blood pressure. However, recent findings indicate that lycopene could exert cardiovascular protection by lowering HDL-associated inflammation, as well as by modulating HDL functionality towards an antiatherogenic phenotype. Furthermore, in vitro studies indicate that lycopene could modulate T lymphocyte activity, which would also inhibit atherogenic processes and confer cardiovascular protection. These findings also suggest that HDL functionality deserves further consideration as a potential early marker for CVD risk, modifiable by dietary factors such as lycopene.
Original languageEnglish
Pages (from-to)122-129
Number of pages8
JournalProceedings of the Nutrition Society
Volume76
Issue number2
Early online date9 Sep 2016
DOIs
Publication statusPublished - May 2017
EventNutrition Society Scottish Section Conference on ‘Phytochemicals and health: new perspectives on plant-based nutrition’: Symposium 3: Phytochemicals for healthier foods - The Royal College of Physicians, Edinburgh, United Kingdom
Duration: 21 Mar 201622 Mar 2016

Fingerprint

Fantasy
Lycopersicon esculentum
Heart Neoplasms
Platelet Activation
Retinoids
Carotenoids
C-Reactive Protein
Lipid Peroxidation
DNA Damage
Heart Diseases
Chronic Disease
Cholesterol
lycopene
Apoptosis
Blood Pressure
Inflammation
T-Lymphocytes
Phenotype
Lipids
Neoplasms

Keywords

  • lycopene
  • cardiovascular health
  • intervention trials
  • mechanisms

Cite this

Cardiovascular benefits of lycopene : fantasy or reality? / Thies, Frank; Mills, Lynsey Margaret; Moir, Susan; Masson, Lindsey F.

In: Proceedings of the Nutrition Society, Vol. 76, No. 2, 05.2017, p. 122-129.

Research output: Contribution to journalArticle

@article{c9e738023ceb4faa9fd8f7827626a5fd,
title = "Cardiovascular benefits of lycopene: fantasy or reality?",
abstract = "Epidemiological evidence indicates that high consumption of tomatoes and tomato-based products reduces the risk of chronic diseases such as CVD and cancer. Such potential benefits are often ascribed to high concentrations of lycopene present in tomato products. Mainly from the results of in vitro studies, potential biological mechanisms by which carotenoids could protect against heart disease and cancer have been suggested. These include cholesterol reduction, inhibition of oxidation processes, modulation of inflammatory markers, enhanced intercellular communication, inhibition of tumourigenesis and induction of apoptosis, metabolism to retinoids and antiangiogenic effects. However, with regard to CVD, results from intervention studies gave mixed results. Over fifty human intervention trials with lycopene supplements or tomato-based products have been conducted to date, the majority being underpowered. Many showed some beneficial effects but mostly on non-established cardiovascular risk markers such as lipid peroxidation, DNA oxidative damage, platelet activation and inflammatory markers. Only a few studies showed improvement in lipid profiles, C reactive protein and blood pressure. However, recent findings indicate that lycopene could exert cardiovascular protection by lowering HDL-associated inflammation, as well as by modulating HDL functionality towards an antiatherogenic phenotype. Furthermore, in vitro studies indicate that lycopene could modulate T lymphocyte activity, which would also inhibit atherogenic processes and confer cardiovascular protection. These findings also suggest that HDL functionality deserves further consideration as a potential early marker for CVD risk, modifiable by dietary factors such as lycopene.",
keywords = "lycopene, cardiovascular health, intervention trials, mechanisms",
author = "Frank Thies and Mills, {Lynsey Margaret} and Susan Moir and Masson, {Lindsey F.}",
note = "Acknowledgements F. T. and S. M. are grateful for support from the Scottish Government (Rural and Environmental Science and Analytical Services). Financial Support F. T. and L. F. M. received funding from the UK Food Standard Agency for tomato and lycopene-related research",
year = "2017",
month = "5",
doi = "10.1017/S0029665116000744",
language = "English",
volume = "76",
pages = "122--129",
journal = "Proceedings of the Nutrition Society",
issn = "0029-6651",
publisher = "Cambridge Univ. Press.",
number = "2",

}

TY - JOUR

T1 - Cardiovascular benefits of lycopene

T2 - fantasy or reality?

AU - Thies, Frank

AU - Mills, Lynsey Margaret

AU - Moir, Susan

AU - Masson, Lindsey F.

N1 - Acknowledgements F. T. and S. M. are grateful for support from the Scottish Government (Rural and Environmental Science and Analytical Services). Financial Support F. T. and L. F. M. received funding from the UK Food Standard Agency for tomato and lycopene-related research

PY - 2017/5

Y1 - 2017/5

N2 - Epidemiological evidence indicates that high consumption of tomatoes and tomato-based products reduces the risk of chronic diseases such as CVD and cancer. Such potential benefits are often ascribed to high concentrations of lycopene present in tomato products. Mainly from the results of in vitro studies, potential biological mechanisms by which carotenoids could protect against heart disease and cancer have been suggested. These include cholesterol reduction, inhibition of oxidation processes, modulation of inflammatory markers, enhanced intercellular communication, inhibition of tumourigenesis and induction of apoptosis, metabolism to retinoids and antiangiogenic effects. However, with regard to CVD, results from intervention studies gave mixed results. Over fifty human intervention trials with lycopene supplements or tomato-based products have been conducted to date, the majority being underpowered. Many showed some beneficial effects but mostly on non-established cardiovascular risk markers such as lipid peroxidation, DNA oxidative damage, platelet activation and inflammatory markers. Only a few studies showed improvement in lipid profiles, C reactive protein and blood pressure. However, recent findings indicate that lycopene could exert cardiovascular protection by lowering HDL-associated inflammation, as well as by modulating HDL functionality towards an antiatherogenic phenotype. Furthermore, in vitro studies indicate that lycopene could modulate T lymphocyte activity, which would also inhibit atherogenic processes and confer cardiovascular protection. These findings also suggest that HDL functionality deserves further consideration as a potential early marker for CVD risk, modifiable by dietary factors such as lycopene.

AB - Epidemiological evidence indicates that high consumption of tomatoes and tomato-based products reduces the risk of chronic diseases such as CVD and cancer. Such potential benefits are often ascribed to high concentrations of lycopene present in tomato products. Mainly from the results of in vitro studies, potential biological mechanisms by which carotenoids could protect against heart disease and cancer have been suggested. These include cholesterol reduction, inhibition of oxidation processes, modulation of inflammatory markers, enhanced intercellular communication, inhibition of tumourigenesis and induction of apoptosis, metabolism to retinoids and antiangiogenic effects. However, with regard to CVD, results from intervention studies gave mixed results. Over fifty human intervention trials with lycopene supplements or tomato-based products have been conducted to date, the majority being underpowered. Many showed some beneficial effects but mostly on non-established cardiovascular risk markers such as lipid peroxidation, DNA oxidative damage, platelet activation and inflammatory markers. Only a few studies showed improvement in lipid profiles, C reactive protein and blood pressure. However, recent findings indicate that lycopene could exert cardiovascular protection by lowering HDL-associated inflammation, as well as by modulating HDL functionality towards an antiatherogenic phenotype. Furthermore, in vitro studies indicate that lycopene could modulate T lymphocyte activity, which would also inhibit atherogenic processes and confer cardiovascular protection. These findings also suggest that HDL functionality deserves further consideration as a potential early marker for CVD risk, modifiable by dietary factors such as lycopene.

KW - lycopene

KW - cardiovascular health

KW - intervention trials

KW - mechanisms

U2 - 10.1017/S0029665116000744

DO - 10.1017/S0029665116000744

M3 - Article

VL - 76

SP - 122

EP - 129

JO - Proceedings of the Nutrition Society

JF - Proceedings of the Nutrition Society

SN - 0029-6651

IS - 2

ER -